000504.SZ
南华生物
SZSE · Healthcare · M 科研服务 · CN
CNY 8.14
−3.44%Margins
Gross margin
19.8%
EBITDA margin
9.5%
EBIT margin
7.3%
Net margin
8.2%
FCF margin
-41.6%
15.2%
Return on equity
4.1%
Return on assets
6.1%
Return on invested capital
0.51x
Asset turnover
-CNY 205.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026